DE69117943D1 - Behandlung von tieren - Google Patents

Behandlung von tieren

Info

Publication number
DE69117943D1
DE69117943D1 DE69117943T DE69117943T DE69117943D1 DE 69117943 D1 DE69117943 D1 DE 69117943D1 DE 69117943 T DE69117943 T DE 69117943T DE 69117943 T DE69117943 T DE 69117943T DE 69117943 D1 DE69117943 D1 DE 69117943D1
Authority
DE
Germany
Prior art keywords
treatment
animals
veterinarily acceptable
acceptable derivative
amoxycillin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69117943T
Other languages
English (en)
Other versions
DE69117943T2 (de
Inventor
Victor Cracknell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE69117943D1 publication Critical patent/DE69117943D1/de
Publication of DE69117943T2 publication Critical patent/DE69117943T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Soil Working Implements (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69117943T 1990-03-30 1991-03-25 Behandlung von tieren Expired - Fee Related DE69117943T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909007143A GB9007143D0 (en) 1990-03-30 1990-03-30 Veterinary composition
PCT/GB1991/000442 WO1991015208A1 (en) 1990-03-30 1991-03-25 Veterinary treatment

Publications (2)

Publication Number Publication Date
DE69117943D1 true DE69117943D1 (de) 1996-04-18
DE69117943T2 DE69117943T2 (de) 1996-08-01

Family

ID=10673543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69117943T Expired - Fee Related DE69117943T2 (de) 1990-03-30 1991-03-25 Behandlung von tieren

Country Status (15)

Country Link
EP (1) EP0521974B1 (de)
JP (1) JP3032904B2 (de)
KR (1) KR100190869B1 (de)
AT (1) ATE135213T1 (de)
AU (1) AU648787B2 (de)
CA (1) CA2079328C (de)
DE (1) DE69117943T2 (de)
DK (1) DK0521974T3 (de)
ES (1) ES2085990T3 (de)
GB (1) GB9007143D0 (de)
GR (1) GR3020197T3 (de)
IE (1) IE71191B1 (de)
NZ (1) NZ237615A (de)
WO (1) WO1991015208A1 (de)
ZA (1) ZA912369B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT64897B (en) * 1975-04-14 1977-08-18 Beecham Group Ltd Process for the preparation of novel antibacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
ES2085990T3 (es) 1996-06-16
DE69117943T2 (de) 1996-08-01
WO1991015208A1 (en) 1991-10-17
GR3020197T3 (en) 1996-09-30
DK0521974T3 (da) 1996-04-15
JP3032904B2 (ja) 2000-04-17
JPH05505818A (ja) 1993-08-26
EP0521974B1 (de) 1996-03-13
AU648787B2 (en) 1994-05-05
AU7570891A (en) 1991-10-30
NZ237615A (en) 1992-01-29
CA2079328A1 (en) 1991-10-01
EP0521974A1 (de) 1993-01-13
KR930700098A (ko) 1993-03-13
ZA912369B (en) 1992-02-26
IE911074A1 (en) 1991-10-09
CA2079328C (en) 2002-01-29
GB9007143D0 (en) 1990-05-30
IE71191B1 (en) 1997-02-12
ATE135213T1 (de) 1996-03-15
KR100190869B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
NO891896L (no) Fremgangsmaate og innretning for behandling av medisinsk spesialavfall.
DE3854540D1 (de) Behandlungsapparat und Verfahren.
ATE206918T1 (de) Isoxazolderivate zur behandlung von darmreizungssyndromen
NO914352L (no) Fremgangsmaate for behandling av brukte katodebunner
MX9100051A (es) Mezcla esterilizante y metodo de esterilizacion
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE68909465D1 (de) Behandlung von pferdeviehbestand.
DE69117943D1 (de) Behandlung von tieren
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
NO900771D0 (no) Anordning for behandling av krympeplast.
ATE96317T1 (de) Verwendung von 5-(subst. phenyl)oxazolidinonderivaten zur behandlung von depressionen.
DE69132663D1 (de) Tierärztliche behandlung
ES2138053T3 (es) Formulacion insecticida solida.
NO890245D0 (no) Isoxazoler med nootrop aktivitet.
FI102810B1 (fi) Aine eläimen ihon käsittelyyn
ATE121273T1 (de) Verwendung von carbomethoxy-2-pyrroline-1.
NO905643L (no) Fremgangsmaate for behandling av manganslam.
UA15825A (uk) Спосіб одержаhhя пробіотика "лактосаh" для поросят
ATE95036T1 (de) Behandlung von pferdeviehbestand.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PFIZER INC. (N.D.GES.D. STAATES DELAWARE), NEW YOR

8328 Change in the person/name/address of the agent

Free format text: BOEHMERT & BOEHMERT, 28209 BREMEN

8328 Change in the person/name/address of the agent

Free format text: LEDERER, KELLER & RIEDERER, 80538 MUENCHEN

8339 Ceased/non-payment of the annual fee